Details for 2017719380

Up to date per 02.04.2026

Actions

Title / Product Name

INVERSE 5-HT2A-SEROTONIN-REZEPTOR-AGONISTEN ODER -ANTAGONISTEN ZUR VERWENDUNG IN DER VERRINGERUNG VON AMYLOID-BETA-PEPTIDEN UND IN DER VERRINGERUNG DER AKKUMULATION VON AMYLOID-PLAQUES

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017719380

EP Publication Number

3436010

E-Number

1369041

Language

PCT Number

US17024526

Publication Date

06.02.2019 A

10.03.2021 B1

Registration Date

10.03.2021

AT Publication Date

15.03.2021

Application Date

28.03.2017

Registration Number

Priorities

29.03.2016

201662314857 P

04.04.2016

1630067

IPC

A61K 31/445 20060101AFI20171006BHEP

Maximum Duration of Protection

28.03.2037

Owner

Acadia Pharmaceuticals Inc.12830 El Camino Real, Suite 400 San Diego, CA 92130US

Representative

No representatives present

Inventor

BURSTEIN, Ethan4168 Sturgeon Court San Diego, CA 92130US